Skip to content

Care&D

Active
Private limited companyfounded 2017active for 9 yearsRue de Lonnoux 2, 6880 Bertrix, BelgiumKBO/BCE: BE 0676.669.426

From the official registers: KBO 8 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Care&D has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €64,428 and a net result of €17,929. Equity has been shrinking by about 3.6% per year since 2018. Its solvency ranks better than 58% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 09-06-2017 Normal situation
Activity
Research and development on biotechnology NACE 72101and 1 other
Establishment unit
2.265.711.251 6880 Bertrix, since 01-07-2017
Financial year end
31 December
Peppol
Reachable since 20-11-2020

Board and ownership

Board
  • GENIN EtienneDirector · since 11-05-2020

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€208,618
▲ 37.9%
Turnover
≈ €530,000
estimated
Profit
€17,929
Equity
€64,428
▲ 38.6%
Total assets
€112,187
▲ 23.9%
Employees on 31-12-2025
3
=
Filed on 13-07-2026, 18 days before the deadline
Score breakdownraises riskSize: 2.7 FTE, total assets €112,187lowers riskLiquidity: current ratio 2.35, cash €23,470Sector: Scientific research and development (NACE 72)Equity €64,428 (57.4% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 58% of micro companies in research and development (NACE 72)
Financial strength · tick: 2024
Strong
Solvency 82+6
equity 57.4% of total assets
Liquidity 56-3
short-term debt 42.6% · cash 20.9%
Profitability 77+60
return on assets 16.0%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.3%▲ +0.1 percentage points vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026highest value 08-2026: 0.1%▼ -0.2 percentage points vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €6,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.35 (2.05 in 2024), above the usual 1.5. Short-term debt is 42.6% and cash 20.9% of total assets. 42.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 50% of them on solvency, 44% on liquidity, 52% on profitability and 85% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.35, cash €23,470
NBB · annual accounts
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
raises risk · Size: 2.7 FTE, total assets €112,187
Companies of this size fail more often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €64,428 (57.4% of total assets)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €64,428
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
18 days early
2024
48 days early
2023
14 days early
2022
47 days early
2021
30 days early
2020
18 days late
2019
14 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 22 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

Comparable companies

These companies have the same main activity as Care&D: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €47,100 and €630,000, founded between 2011 and 2018.

CompanyTotal assetsGross margin
Care&D Bertrix€112,187€208,618
LACTO RESEARCH Gembloux€360,033€166,563
OPIS BELGIUM Brussel€630,008€334,290
STXC Aalst€210,455€242,147
Base LT Herbeumont€47,144€77,947
FOXY Vielsalm€153,611€12,833
THALEN BIOTECH CONSULTANCY Frasnes-lez-Anvaing€215,550€221,552
Full comparison

Documents

Annual accounts at the NBB

All 8 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Care&D

What is the company number of Care&D?
The company number of Care&D is 0676.669.426. The VAT number is the same number with BE in front: BE 0676.669.426.
Where is Care&D based?
The registered office is at Rue de Lonnoux 2, 6880 Bertrix.Company details
What does Care&D do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of Care&D?
The legal form of Care&D is Private limited company (BV).
When was Care&D founded?
Care&D was founded on 09-06-2017.
Is Care&D still active?
Yes, Care&D is an active enterprise in the KBO register.
How many employees does Care&D have?
Care&D had an average of 2.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Care&D?
The turnover in financial year 2025 is ≈ €530,000. This figure is estimated from the gross margin of €208,618 and 1,644 comparable companies of the same size. It probably lies between €320,000 and €990,000. It is a rough estimate.
Is Care&D profitable?
In financial year 2025, Care&D made a profit of €17,929.
Where can I find the annual accounts of Care&D?
Care&D filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Care&D due?
Care&D must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.